Jennifer Ruddock | Senior Vice President, Strategy and Corporate Affairs |
Howard Robin | President and Chief Executive Officer |
Gil Labrucherie | Chief Operating Officer and Chief Financial Officer |
Jonathan Zalevsky | Chief, Research and Development |
Wei Lin | Head, Development |
Peter Lawson | Barclays |
Tyler Van Buren | Piper Sandler |
Chris Shibutani | Cowen |
Alex Lim | Mizuho |
Gobind Singh | BMO Capital Markets |
Aydin Huseynov | Benchmark |
Jay Olson | Oppenheimer |
Corinne Jenkins | Goldman Sachs |
Daina Graybosch | SVB Leerink |
Ladies and gentlemen, thank you for standing by and welcome to the Nektar Therapeutics Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Jennifer Ruddock, Head of Corporate Affairs. Ma’am, you may begin.
Thank you, Crystal.